| # | Drug | Count |
|---|---|---|
| 0 | EFGARTIGIMOD ALFA | 455 |
| 1 | ECULIZUMAB | 209 |
| 2 | PREDNISONE | 190 |
| 3 | PYRIDOSTIGMINE BROMIDE | 173 |
| 4 | PYRIDOSTIGMINE BROMIDE ORAL | 170 |
| 5 | RAVULIZUMAB | 141 |
| 6 | PREDNISOLONE | 117 |
| 7 | PREDNISOLONE ORAL | 117 |
| 8 | PREDNISOLONE ORAL SOLUTION | 117 |
| 9 | AZATHIOPRINE | 90 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFGARTIGIMOD ALFA | 455 | 0.1147 |
| 1 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 25 | 0.0515 |
| 2 | PYRIDOSTIGMINE BROMIDE ORAL | 170 | 0.0478 |
| 3 | LIDOCAINE 4% MENTHOL 1% | 1 | 0.0417 |
| 4 | PYRIDOSTIGMINE BROMIDE | 173 | 0.0227 |
| 5 | NIPOCALIMAB-AAHU | 5 | 0.0157 |
| 6 | SUCCINYLCHOLINE CHLORIDE | 9 | 0.0040 |
| 7 | ECULIZUMAB | 209 | 0.0038 |
| 8 | DEFLAZACORT | 9 | 0.0035 |
| 9 | GLYCERINE | 1 | 0.0031 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 525 | 0.1197 |
| 1 | Endoglycosidase [EPC] | 25 | 0.0135 |
| 2 | Complement Inhibitor [EPC] | 323 | 0.0057 |
| 3 | CD19-directed Cytolytic Antibody [EPC] | 4 | 0.0047 |
| 4 | Human Immunoglobulin G [EPC] | 64 | 0.0030 |
| 5 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 6 | Lipopeptide Antibacterial [EPC] | 18 | 0.0019 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 8 | Tetracycline-class Antibacterial [EPC] | 11 | 0.0014 |
| 9 | Provitamin D2 Compound [EPC] | 31 | 0.0010 |